MedPath
NMPA Approval

Buprenorphine Hydrochloride Injection

国药准字H12020275

August 4, 2020

Drug Information

盐酸丁丙诺啡注射液

注射剂

1ml∶0.15mg

化学药品

August 4, 2020

Company Information

Manufacturing Company

天津滨海高新区滨海科技园惠新路29号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸丁丙诺啡注射液 - NMPA 批准文号 | MedPath